A Study of RAY1225 in Participants With Type 2 Diabetes

NCT06254274 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

T2DM (Type 2 Diabetes Mellitus)

Interventions

DRUG: RAY1225
DRUG: Placebo

Sponsor

Guangdong Raynovent Biotech Co., Ltd